Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist.

Precision Medicine Humans Checklist Biomedical Research / standards Research Design / standards Guidelines as Topic Clinical Relevance

Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 21 03 2024
accepted: 29 04 2024
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 19 7 2024
Statut: ppublish

Résumé

Precision medicine should aspire to reduce error and improve accuracy in medical and health recommendations by comparison with contemporary practice, while maintaining safety and cost-effectiveness. The etiology, clinical manifestation and prognosis of diseases such as obesity, diabetes, cardiovascular disease, kidney disease and fatty liver disease are heterogeneous. Without standardized reporting, this heterogeneity, combined with the diversity of research tools used in precision medicine studies, makes comparisons across studies and implementation of the findings challenging. Specific recommendations for reporting precision medicine research do not currently exist. The BePRECISE (Better Precision-data Reporting of Evidence from Clinical Intervention Studies & Epidemiology) consortium, comprising 23 experts in precision medicine, cardiometabolic diseases, statistics, editorial and lived experience, conducted a scoping review and participated in a modified Delphi and nominal group technique process to develop guidelines for reporting precision medicine research. The BePRECISE checklist comprises 23 items organized into 5 sections that align with typical sections of a scientific publication. A specific section about health equity serves to encourage precision medicine research to be inclusive of individuals and communities that are traditionally under-represented in clinical research and/or underserved by health systems. Adoption of BePRECISE by investigators, reviewers and editors will facilitate and accelerate equitable clinical implementation of precision medicine.

Identifiants

DOI: 10.1038/s41591-024-03033-3 PMID: 39030405
pubmed: 39030405
doi: 10.1038/s41591-024-03033-3
pii: 10.1038/s41591-024-03033-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1874-1881

Subventions

Organisme : Vetenskapsrådet (Swedish Research Council)
ID : #2019-01348
Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 2018-02837
Organisme : Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research)
ID : LUDC-IRC, 15-0067
Organisme : Stiftelsen för Strategisk Forskning (Swedish Foundation for Strategic Research)
ID : LUDC-IRC, 15-0067
Organisme : Innovative Medicines Initiative (IMI)
ID : 115974 - BEAt-DKD
Organisme : Innovative Medicines Initiative (IMI)
ID : 115974 - BEAt-DKD
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/N00633X/1
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF23SA0084103, NNF18CC0034900, NNF20OC0059313
Organisme : JDRF
ID : 2-SRA-202201260-S-B
Pays : United States

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Chung, W. K. et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43, 1617–1635 (2020).
doi: 10.2337/dci20-0022 pubmed: 32561617 pmcid: 7305007
Chung, W. K. et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 63, 1671–1693 (2020).
doi: 10.1007/s00125-020-05181-w pubmed: 32556613 pmcid: 8185455
Tobias, D. K. et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat. Med. 29, 2438–2457 (2023).
doi: 10.1038/s41591-023-02502-5 pubmed: 37794253 pmcid: 10735053
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
doi: 10.1016/S0140-6736(20)30925-9
Sun, H. et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).
doi: 10.1016/j.diabres.2021.109119 pubmed: 34879977
Ahmad, A. et al. Precision prognostics for cardiovascular disease in type 2 diabetes: a systematic review and meta-analysis. Commun. Med. 4, 11 (2024).
doi: 10.1038/s43856-023-00429-z pubmed: 38253823 pmcid: 10803333
Semnani-Azad, Z. et al. Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review. Commun. Med. 4, 9 (2024).
doi: 10.1038/s43856-023-00427-1 pubmed: 38216688 pmcid: 10786838
Francis, E. C. et al. Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis. Commun. Med. 3, 185 (2023).
doi: 10.1038/s43856-023-00393-8 pubmed: 38110524 pmcid: 10728189
Misra, S. et al. Precision subclassification of type 2 diabetes: a systematic review. Commun. Med. 3, 138 (2023).
doi: 10.1038/s43856-023-00360-3 pubmed: 37798471 pmcid: 10556101
Benham, J. L. et al. Precision gestational diabetes treatment: a systematic review and meta-analyses. Commun. Med. 3, 135 (2023).
doi: 10.1038/s43856-023-00371-0 pubmed: 37794196 pmcid: 10550921
Felton, J. L. et al. Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review. Commun. Med. 3, 130 (2023).
doi: 10.1038/s43856-023-00357-y pubmed: 37794169 pmcid: 10550983
Murphy, R. et al. The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion. Commun. Med. 3, 136 (2023).
doi: 10.1038/s43856-023-00369-8 pubmed: 37794142 pmcid: 10550998
Lim, S. et al. Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis. Commun. Med. 3, 137 (2023).
doi: 10.1038/s43856-023-00366-x pubmed: 37794119 pmcid: 10551015
Jacobsen, L. M. et al. Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Commun. Med. 3, 132 (2023).
doi: 10.1038/s43856-023-00358-x pubmed: 37794113 pmcid: 10550996
Semple, R. K., Patel, K. A., Auh, S., Ada/Easd, P. & Brown, R. J. Genotype-stratified treatment for monogenic insulin resistance: a systematic review. Commun. Med. 3, 134 (2023).
doi: 10.1038/s43856-023-00368-9 pubmed: 37794082 pmcid: 10550936
Naylor, R. N. et al. Systematic review of treatment of beta-cell monogenic diabetes. Preprint at medRxiv https://doi.org/10.1101/2023.05.12.23289807 (2023).
Schulz, K. F., Altman, D. G., Moher, D.& the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 7, e1000251 (2010).
doi: 10.1371/journal.pmed.1000251 pubmed: 20352064 pmcid: 2844794
Cuschieri, S. The STROBE guidelines. Saudi J. Anaesth. 13, S31–S34 (2019).
doi: 10.4103/sja.SJA_543_18 pubmed: 30930717 pmcid: 6398292
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br. Med. J. 372, n71 (2021).
doi: 10.1136/bmj.n71
O’Neill, J. et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J. Clin. Epidemiol. 67, 56–64 (2014).
doi: 10.1016/j.jclinepi.2013.08.005 pubmed: 24189091
Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885–1892 (2021).
doi: 10.1038/s41591-021-01552-x pubmed: 34789871 pmcid: 9105086
Hart, J. T. The inverse care law. Lancet i, 405–412 (1971).
doi: 10.1016/S0140-6736(71)92410-X
Kamiza, A. B. et al. Transferability of genetic risk scores in African populations. Nat. Med. 28, 1163–1166 (2022).
doi: 10.1038/s41591-022-01835-x pubmed: 35654908 pmcid: 9205766
Choudhury, A. et al. Meta-analysis of sub-Saharan African studies provides insights into genetic architecture of lipid traits. Nat. Commun. 13, 2578 (2022).
doi: 10.1038/s41467-022-30098-w pubmed: 35546142 pmcid: 9095599
Aiyegbusi, O. L. et al. Considerations for patient and public involvement and engagement in health research. Nat. Med. 29, 1922–1929 (2023).
doi: 10.1038/s41591-023-02445-x pubmed: 37474660
Retzer, A. et al. A toolkit for capturing a representative and equitable sample in health research. Nat. Med. 29, 3259–3267 (2023).
doi: 10.1038/s41591-023-02665-1 pubmed: 38066209 pmcid: 10719102
Calvert, M. et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. J. Am. Med. Assoc. 309, 814–822 (2013).
doi: 10.1001/jama.2013.879
Calvert, M. et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension. J. Am. Med. Assoc. 319, 483–494 (2018).
doi: 10.1001/jama.2017.21903
Rankin, N. M. et al. Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science. BMC Med. Res. Methodol. 16, 110 (2016).
doi: 10.1186/s12874-016-0210-7 pubmed: 27566679 pmcid: 5002198
Tricco, A. C. et al. PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169, 467–473 (2018).
doi: 10.7326/M18-0850 pubmed: 30178033
Welch, V. A. et al. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. Br. Med. J. 359, j5085 (2017).
doi: 10.1136/bmj.j5085
Little, J. et al. STrengthening the REporting of Genetic Association studies (STREGA)—an extension of the STROBE statement. Eur. J. Clin. Invest. 39, 247–266 (2009).
doi: 10.1111/j.1365-2362.2009.02125.x pubmed: 19297801 pmcid: 2730482

Auteurs

Siew S Lim (SS)

Health Systems and Equity, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia.

Zhila Semnani-Azad (Z)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
ORCID: 0000-0001-7822-5072

Mario L Morieri (ML)

Unit of Metabolic Disease, University-Hospital of Padua, Padua, Italy.
Department of Medicine, University of Padua, Padua, Italy.
ORCID: 0000-0001-6864-0547

Ashley H Ng (AH)

Monash Centre for Health Research Implementation, Monash University and Monash Health, Melbourne, Victoria, Australia.
Monash Partners Academic Health Science Centre, Melbourne, Victoria, Australia.
Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.

Abrar Ahmad (A)

Diabetic Complications Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Malmo, Sweden.

Hugo Fitipaldi (H)

Diabetic Complications Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Malmo, Sweden.

Jacqueline Boyle (J)

Health Systems and Equity, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia.

Christian Collin (C)

Board of Directors, Steno Diabetes Center, Copenhagen, Denmark.

John M Dennis (JM)

Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
ORCID: 0000-0002-7171-732X

Claudia Langenberg (C)

Precision Healthcare University Research Institute, Queen Mary University of London, London, UK.
Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
ORCID: 0000-0002-5017-7344

Ruth J F Loos (RJF)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Melinda Morrison (M)

Diabetes Australia, Canberra, Australian Capital Territory, Australia.

Michele Ramsay (M)

Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
ORCID: 0000-0002-4156-4801

Arun J Sanyal (AJ)

Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
ORCID: 0000-0001-8682-5748

Naveed Sattar (N)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
ORCID: 0000-0002-1604-2593

Marie-France Hivert (MF)

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
ORCID: 0000-0001-7752-2585

Maria F Gomez (MF)

Diabetic Complications Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Malmo, Sweden.
ORCID: 0000-0001-6210-3142

Jordi Merino (J)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Diabetes Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA.
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
ORCID: 0000-0001-8312-1438

Deirdre K Tobias (DK)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Michael I Trenell (MI)

Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Stephen S Rich (SS)

Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
ORCID: 0000-0003-3872-7793

Jennifer L Sargent (JL)

School of Public Health, Imperial College London, London, UK.

Paul W Franks (PW)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. paul.franks@med.lu.se.
Department of Clinical Sciences, Lund University, Helsingborg, Sweden. paul.franks@med.lu.se.
ORCID: 0000-0002-0520-7604

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Professions de santé › Médecine › Médecine clinique › Médecine de précision › Reporting guidelines for precision medicine...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Reporting guidelines for precision medicine...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Liste de contrôle › Reporting guidelines for precision medicine...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Reporting guidelines for precision medicine...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Plan de recherche › Reporting guidelines for precision medicine...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Reporting guidelines for precision medicine...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Évaluation des résultats des patients › Pertinence clinique › Reporting guidelines for precision medicine...